新的贝叶斯检测器可在低于检测限的水平发现ctDNA中的癌症耐药性

作者 PulseAugur 编辑部 · [2 个来源] · 2026-06-10 09:59

研究人员开发了一种新的贝叶斯变化点检测器Span，用于分析循环肿瘤DNA（ctDNA）的连续数据。该方法将未检出值视为左删失观测值，从而比传统方法更早地检测到耐药性。在HR+/HER2-转移性乳腺癌的模拟研究中，Span将提前三个月发现即将进展的检测率与快照分析相比提高了约一倍。 AI

影响这种新的统计方法可能通过利用ctDNA的间歇性信号，从而改善癌症患者耐药性的早期检测。

排序理由该集群包含一篇详细介绍新统计方法的学术论文。

AI 生成摘要 · Google Gemini · 来自 2 个来源。我们如何撰写摘要 →

报道来源 [2]

arXiv cs.LG TIER_1 English(EN) · Aarchi Singh Thakur, Abhijoy Sarkar · 2026-06-11 04:00

Seeing Below the Limit of Detection: A Censored-Poisson Bayesian Latent-Growth Change-Point Detector (the Span Detector) for Serial ctDNA in HR+/HER2- Metastatic Breast Cancer

arXiv:2606.11876v1 Announce Type: cross Abstract: Circulating-tumour DNA (ctDNA) carries evidence of drug resistance months before imaging shows it, but the earliest evidence lives below the assay's limit of detection (LoD): a nascent subclone is detected only intermittently, pro…
arXiv cs.LG TIER_1 English(EN) · Abhijoy Sarkar · 2026-06-10 09:59

超越检测限的检测：用于HR+/HER2-转移性乳腺癌连续ctDNA的泊松贝叶斯潜变量增长变化点检测器（Span Detector）

Circulating-tumour DNA (ctDNA) carries evidence of drug resistance months before imaging shows it, but the earliest evidence lives below the assay's limit of detection (LoD): a nascent subclone is detected only intermittently, producing a flickering sequence of faint detects and …